News for 'Drugs Controller General of India'

Margin pressures, growth triggers to weigh on Dr Reddy's

Margin pressures, growth triggers to weigh on Dr Reddy's

Rediff.com21 May 2025

Pharma major Dr Reddy's Laboratories delivered a muted operational performance in the fourth quarter of financial year 2024-25 (Q4FY25), even as revenue growth remained healthy. Lower gross margin performance and muted domestic growth are key concerns. Most brokerages have a "Sell" or "Reduce" rating as there are uncertainties related to the development of a new product portfolio and the launch timelines.

Covid vaccine 110% safe: DCGI rubbishes rumours

Covid vaccine 110% safe: DCGI rubbishes rumours

Rediff.com3 Jan 2021

"We will never approve anything if there is even the slightest safety concern. Vaccines are 110 per cent safe. Some side effects like mild fever, pain and allergy are common for every vaccine. "It (rumours of impotency) is complete nonsense," V G Somani, Drug Controller General of India said.

Zydus's India-made Covid vaccine gets emergency use approval

Zydus's India-made Covid vaccine gets emergency use approval

Rediff.com20 Aug 2021

This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance

CBI to probe drug imports from China

CBI to probe drug imports from China

Rediff.com27 Nov 2009

Unregistered sources of consignment raise quality questions.

Testing times for Indian drug makers

Testing times for Indian drug makers

Rediff.com24 Oct 2007

Sixty firms' business worth Rs 1,000 crore at stake.

Record 3,300 kg of drugs seized off Gujarat coast in major drug haul

Record 3,300 kg of drugs seized off Gujarat coast in major drug haul

Rediff.com29 Feb 2024

The drugs seized include 3,089 kilograms of charas, 158 kg of Methamphetamine and 25 kg of morphine.

DCGI extends shelf life of Covishield from 6 to 9 months

DCGI extends shelf life of Covishield from 6 to 9 months

Rediff.com31 Mar 2021

The DCGI said it has no objection in respect of 'Extension of Shelf Life of Covishield Vaccine' in multi-dose glass vial (10 dose-5ml) from six months to nine months.

Bayer's attempt to stop Cipla drug sale fails

Bayer's attempt to stop Cipla drug sale fails

Rediff.com19 Aug 2009

Court rejects bid to introduce a linkage between regulatory approval of a medicine and its patent status.

Why Drug Prices Won't Increase This Year

Why Drug Prices Won't Increase This Year

Rediff.com5 Apr 2024

The government has been stringent with pricing changes. Prices of 651 essential medicines came down from April 1, 2023 by 6.73 per cent with the government capping ceiling prices of these drugs.

Covovax as Covid booster jab to be available on CoWIN soon

Covovax as Covid booster jab to be available on CoWIN soon

Rediff.com10 Apr 2023

Covovax is likely to be available on the portal in a few days at a price of Rs 225 per dose plus applicable GST.

Dr Reddy's launches COVID-19 drug Avigan

Dr Reddy's launches COVID-19 drug Avigan

Rediff.com19 Aug 2020

Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life.

Uzbek syrup deaths: India begins probe, manufacturing halted

Uzbek syrup deaths: India begins probe, manufacturing halted

Rediff.com29 Dec 2022

Samples of the cough syrup have been taken from the manufacturing premises in Noida and sent to the Regional Drugs Testing Laboratory (RDTL) in Chandigarh for testing, Mandaviya said.

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

Rediff.com20 Jul 2020

The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective in comorbid conditions like diabetes, hypertension, according to protocol summary (of clinical trials) the trial was not designed to access the Fabiflu in comorbid conditions.

India approves nasal Covid vaccine amid global surge

India approves nasal Covid vaccine amid global surge

Rediff.com23 Dec 2022

The needle-free vaccine will be available at private centres.

MSD awaits nod for cervical cancer drug

MSD awaits nod for cervical cancer drug

Rediff.com9 May 2008

MSD Pharmaceuticals, the wholly owned Indian subsidiary of Merck, is awaiting approval from the Drug Controller General of India to launch a human papillomavirus vaccine to treat cervical cancer. The company has already conducted clinical trials.

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

India's drug inspectors hard-pressed to scrutinise factories

India's drug inspectors hard-pressed to scrutinise factories

Rediff.com7 Apr 2014

There are just 1,500 drug inspectors responsible for more than 10,000 factories in India

After Gambia, Uzbekistan links deaths of 18 kids to Indian syrup

After Gambia, Uzbekistan links deaths of 18 kids to Indian syrup

Rediff.com29 Dec 2022

According to the ministry, chemical ethylene glycol was found in a batch of syrup during laboratory tests.

Biocon to seek nod for cancer drug

Biocon to seek nod for cancer drug

Rediff.com28 Apr 2006

Biocon Ltd ill seek Drug Controller General of India's approval for its novel monoclonal antibody indicated towards the treatment of head and neck cancer, Biomab EGFR.

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Rediff.com9 Mar 2024

The Narcotics Control Bureau (NCB) on Saturday said it has arrested Jaffer Sadiq, a Tamil Nadu-based alleged dealer of narcotics, in connection with an international drugs trafficking investigation case.

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Rediff.com10 Jun 2013

Earlier, Jaslok Hospital had issued an advisory to its doctors to avoid prescribing drugs manufactured by Ranbaxy.

India probes four cough syrups after 66 Gambian children's deaths

India probes four cough syrups after 66 Gambian children's deaths

Rediff.com6 Oct 2022

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially be linked to the death of children in Gambia.

ED probes money laundering in drug case linked to DMK ex-functionary

ED probes money laundering in drug case linked to DMK ex-functionary

Rediff.com10 Mar 2024

The ED will probe if money earned from the illicit narcotics trade was laundered to create movable and immovable assets by the accused. The investigation will run parallel to the NCB probe, the sources said.

Bharat Biotech seeks nod for trial of intranasal vax as booster dose

Bharat Biotech seeks nod for trial of intranasal vax as booster dose

Rediff.com20 Dec 2021

An intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to prevent transmission.

COVID-19: Govt bans export of anti-malarial drug

COVID-19: Govt bans export of anti-malarial drug

Rediff.com25 Mar 2020

Indian Council of Medical Research Director General Balram Bhargava had on Monday recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases.

Regulator lifts ban on Wockhardt drug

Regulator lifts ban on Wockhardt drug

Rediff.com28 Apr 2014

Wockhardt said, the drug regulator suspended the manufacture, sale or distribution of fixed dose combination of Dicyclomine Hydrochloride IP 10mg

V G Somani: The head of DCGI known as man of actions, not of words

V G Somani: The head of DCGI known as man of actions, not of words

Rediff.com18 Jan 2021

'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'

Pharma co mired in syrup deaths shuts production at Noida unit

Pharma co mired in syrup deaths shuts production at Noida unit

Rediff.com30 Dec 2022

The move has come days after the state government announced to form a special investigation team to probe into the death of Disha Salian, the former manager of late actor Sushant Singh Rajput.

Serum Institute to start manufacturing Sputnik vaccine in September

Serum Institute to start manufacturing Sputnik vaccine in September

Rediff.com13 Jul 2021

The parties intend to produce over 300 million doses of the vaccine in India per year.

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Rediff.com5 Aug 2020

Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.

Serum Institute seeks nod to manufacture Sputnik V vaccine

Serum Institute seeks nod to manufacture Sputnik V vaccine

Rediff.com3 Jun 2021

Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories.

DCGI approves market authorisation for Covovax as Covid booster dose

DCGI approves market authorisation for Covovax as Covid booster dose

Rediff.com17 Jan 2023

The DCGI's approval came following recommendation by the Subject Expert Committee of the Central Drugs Standard Control Organisation.

Prescription drugs still available online

Prescription drugs still available online

Rediff.com4 May 2015

The FDA Maharashtra on Friday lodged an FIR against Snapdeal.

Why is Novartis likely to lose Tiamulin drug licence?

Why is Novartis likely to lose Tiamulin drug licence?

Rediff.com19 Mar 2014

Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.

Cough syrup deaths: DCGI bans use of propylene glycol supplied by Delhi firm

Cough syrup deaths: DCGI bans use of propylene glycol supplied by Delhi firm

Rediff.com11 Mar 2023

Maya Chemtech India Pvt Ltd supplied propylene glycol used in Marion Biotech's cough syrups that were found to be "not of standard quality", according to the regulator.

DRDO's 1st batch of anti-Covid drug 2DG launched

DRDO's 1st batch of anti-Covid drug 2DG launched

Rediff.com17 May 2021

The drug comes in powder form in a sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.

Drug to treat mild, moderate COVID-19 launched in India

Drug to treat mild, moderate COVID-19 launched in India

Rediff.com20 Jun 2020

FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms.